Compare Humana Inc (HUM) vs Vanguard S&P 500 ETF (VOO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Vanguard S&P 500 ETF — how do they compare? Humana Inc trades at $448.48 (market cap $46.49B), while Vanguard S&P 500 ETF trades at $714.25 (market cap $1.80T). The key difference: Vanguard S&P 500 ETF is far larger — about 38.7× Humana Inc's market cap, and Humana Inc pays a 0.91% dividend while Vanguard S&P 500 ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Vanguard S&P 500 ETF for 55 Days on average.
| HUM | VOO | |
|---|---|---|
Market Cap | $46.49B | $1.80T |
Volume | 2,567,704 | 4,722,271 |
Sector | Health | Broad Market / Factor |
52-Week High | $409.85 | $716.17 |
52-Week Low | $163.67 | $580.93 |
Typical Hold Time | 53 Days | 55 Days |
Enterprise Value | $53.84B | — |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
VOO trades at $714.42, down 0.24% with a mild bearish daily move. Technical indicators show a bullish moving average signal but neutral oscillators, with RSI at 75.83 suggesting potential overbought conditions. Recent news highlights the ETF's role in long-term wealth building amid expectations of slowing S&P 500 profit growth from 35% to 15% in 2027. Short interest increased 46.9% in September, indicating growing bearish bets.
The outlook remains cautiously optimistic given VOO's diversified exposure to the S&P 500, though elevated RSI and rising short interest signal near-term pressure. Key risks include macroeconomic headwinds from Fed rate hikes and projected earnings slowdown. The ETF continues to be favored for recession resilience and long-term dollar-cost averaging strategies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Vanguard S&P 500 ETF
VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.
Read more on VOO →
